Clinical Trials · NCT05794581
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Carmot Therapeutics, Inc.
- Enrollment
- 32
- Start date
- Mar 2023
- Locations
- 1 site, United States
- Primary endpoint
- To assess area under the curve (AUC) in glucose metabolism during MMTT